These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 30066797)

  • 1. Is transcranial sonography useful for diagnosing Parkinson's disease in clinical practice?
    Grippe TC; Allam N; Brandão PRP; Pereira DA; Cardoso FEC; Aguilar ACR; Kessler IM
    Arq Neuropsiquiatr; 2018 Jul; 76(7):459-466. PubMed ID: 30066797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Usefulness of Cardiac MIBG Scintigraphy, Olfactory Testing and Substantia Nigra Hyperechogenicity as Additional Diagnostic Markers for Distinguishing between Parkinson's Disease and Atypical Parkinsonian Syndromes.
    Fujita H; Suzuki K; Numao A; Watanabe Y; Uchiyama T; Miyamoto T; Miyamoto M; Hirata K
    PLoS One; 2016; 11(11):e0165869. PubMed ID: 27812167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcranial brain sonography findings in discriminating between parkinsonism and idiopathic Parkinson disease.
    Walter U; Dressler D; Probst T; Wolters A; Abu-Mugheisib M; Wittstock M; Benecke R
    Arch Neurol; 2007 Nov; 64(11):1635-40. PubMed ID: 17998447
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differentiating Parkinson's Disease from Essential Tremor Using Transcranial Sonography: A Systematic Review and Meta-Analysis.
    Heim B; Peball M; Hammermeister J; Djamshidian A; Krismer F; Seppi K
    J Parkinsons Dis; 2022; 12(4):1115-1123. PubMed ID: 35180133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinguishing Parkinson's disease and essential tremor with transcranial sonography.
    Budisic M; Trkanjec Z; Bosnjak J; Lovrencic-Huzjan A; Vukovic V; Demarin V
    Acta Neurol Scand; 2009 Jan; 119(1):17-21. PubMed ID: 18549415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Transcranial sonography (TCS) in evaluation of patients with essential tremor].
    Budisić M; Trkanjec Z; Lovrencić-Huzjan A; Supanc V; Vuković V; Demarin V
    Acta Med Croatica; 2009 Dec; 63 Suppl 3():51-4. PubMed ID: 20232670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Substantia nigra hyperechogenicity in essential tremor and Parkinson's disease: a longitudinal study.
    Cardaioli G; Ripandelli F; Paolini Paoletti F; Nigro P; Simoni S; Brahimi E; Romoli M; Filidei M; Eusebi P; Calabresi P; Tambasco N
    Eur J Neurol; 2019 Nov; 26(11):1370-1376. PubMed ID: 31094036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The specificity and sensitivity of transcranial ultrasound in the differential diagnosis of Parkinson's disease: a prospective blinded study.
    Gaenslen A; Unmuth B; Godau J; Liepelt I; Di Santo A; Schweitzer KJ; Gasser T; Machulla HJ; Reimold M; Marek K; Berg D
    Lancet Neurol; 2008 May; 7(5):417-24. PubMed ID: 18394965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Substantia nigra hyperechogenicity as a marker for Parkinson's disease: a population-based study.
    Mahlknecht P; Seppi K; Stockner H; Nocker M; Scherfler C; Kiechl S; Willeit J; Schmidauer C; Gasperi A; Rungger G; Poewe W
    Neurodegener Dis; 2013; 12(4):212-8. PubMed ID: 23689066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic Accuracy of Transcranial Sonography of the Substantia Nigra in Parkinson's disease: A Systematic Review and Meta-analysis.
    Li DH; He YC; Liu J; Chen SD
    Sci Rep; 2016 Feb; 6():20863. PubMed ID: 26878893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Substantia nigra hyperechogenicity and Parkinson's disease risk in patients with essential tremor.
    Sprenger FS; Wurster I; Seppi K; Stockner H; Scherfler C; Sojer M; Schmidauer C; Berg D; Poewe W
    Mov Disord; 2016 Apr; 31(4):579-83. PubMed ID: 26893155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcranial sonography of the substantia nigra in Japanese patients with Parkinson's disease or atypical parkinsonism: clinical potential and limitations.
    Okawa M; Miwa H; Kajimoto Y; Hama K; Morita S; Nakanishi I; Kondo T
    Intern Med; 2007; 46(18):1527-31. PubMed ID: 17878638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sonography for diagnosis of Parkinson disease-from theory to practice: a study on 300 participants.
    Alonso-Cánovas A; López-Sendón JL; Buisán J; deFelipe-Mimbrera A; Guillán M; García-Barragán N; Corral I; Matute-Lozano MC; Masjuan J; Martínez-Castrillo JC; Walter U
    J Ultrasound Med; 2014 Dec; 33(12):2069-74. PubMed ID: 25425362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperechogenicity of the substantia nigra in Parkinson's disease.
    Ressner P; Skoloudík D; Hlustík P; Kanovský P
    J Neuroimaging; 2007 Apr; 17(2):164-7. PubMed ID: 17441838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of transcranial sonography-magnetic resonance fusion imaging in Wilson's and early-onset Parkinson's diseases.
    Mašková J; Školoudík D; Burgetová A; Fiala O; Brůha R; Záhoráková D; Serranová T; Slovák M; Ulmanová O; Růžička E; Dušek P
    Parkinsonism Relat Disord; 2016 Jul; 28():87-93. PubMed ID: 27147115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parkinson's disease-like midbrain sonography abnormalities are frequent in depressive disorders.
    Walter U; Hoeppner J; Prudente-Morrissey L; Horowski S; Herpertz SC; Benecke R
    Brain; 2007 Jul; 130(Pt 7):1799-807. PubMed ID: 17329323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperechogenicity of substantia nigra for differential diagnosis of Parkinson's disease: A meta-analysis.
    Shafieesabet A; Fereshtehnejad SM; Shafieesabet A; Delbari A; Baradaran HR; Postuma RB; Lökk J
    Parkinsonism Relat Disord; 2017 Sep; 42():1-11. PubMed ID: 28647434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coronal Transcranial Sonography and M-Mode Tremor Frequency Determination in Parkinson's Disease and Essential Tremor.
    Richter D; Woitalla D; Muhlack S; Gold R; Tönges L; Krogias C
    J Neuroimaging; 2017 Sep; 27(5):524-530. PubMed ID: 28426143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcranial Sonography and DaTSCAN in Early Stage Parkinson's Disease and Essential Tremor.
    Jesus-Ribeiro J; Freire A; Sargento-Freitas J; Sousa M; Silva F; Moreira F; Cunha MJ; Walter U; Januário C
    Eur Neurol; 2016; 76(5-6):252-255. PubMed ID: 27750247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcranial sonography of the substantia nigra and its correlation with DAT-SPECT in the diagnosis of Parkinson's disease.
    Li DH; Zhang LY; Hu YY; Jiang XF; Zhou HY; Yang Q; Kang WY; Liu J; Chen SD
    Parkinsonism Relat Disord; 2015 Aug; 21(8):923-8. PubMed ID: 26066091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.